Establishment of a first-order kinetic model of light chain-associated amyloid fibril extension in vitro

被引:18
作者
Takahashi, N
Hasegawa, K
Yamaguchi, I
Okada, H
Ueda, T
Gejyo, F
Naiki, H
机构
[1] Fukui Med Univ, Dept Pathol, Matsuoka, Fukui 9101193, Japan
[2] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rhematol, Niigata 9518510, Japan
[3] Fukui Med Univ, Dept Internal Med 1, Fukui 9101193, Japan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS | 2002年 / 1601卷 / 01期
关键词
amyloid fibril; light chain-associated amyloidosis; thioflavin T; first-order kinetic model; glycosaminoglycan; nordihydroguaiaretic acid;
D O I
10.1016/S1570-9639(02)00435-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Light chain-associated (AL) amyloidosis is a common and fatal systemic amyloidosis. AL amyloid fibrils (fAL) are composed of intact or fragmental monoclonal light chains (AL proteins). To elucidate the molecular mechanisms of fAL formation from AL proteins, we purified fAL and AL proteins from the amyloid-deposited organs of five AL amyloidosis patients. By electron microscopy and fluorometric thioflavin T method, we observed optimal fibril extension at pH 2.0-3.5 for the fibrils obtained from four patients, while at pH 7.5-8.0 for those obtained from one patient. Fragmental AL proteins were more efficient in the extension reaction than intact AL proteins. The fibrils obtained from all five patients showed clear fibril extension electron microscopically at pH 7.5. The extension of the fibrils obtained from all five patients could be explained by a first-order kinetic model, i.e., fibril extension proceeds via the consecutive association of AL proteins onto the ends of existing fibrils. Fibril extension was accelerated by dermatan sulfate proteoglycan, and inhibited by apolipoprotein E, a I microglobulin, fibronectin, and an antioxidant nordihydroguaiaretic acid. These findings contribute to our understanding of the molecular mechanism underlying the pathogenesis of AL amyloidosis, and will be useful for developing a therapeutic strategy against the disease. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:110 / 120
页数:11
相关论文
共 68 条
[1]   IMMUNOCHEMICAL IDENTIFICATION OF THE SERINE PROTEASE INHIBITOR ALPHA-1-ANTICHYMOTRYPSIN IN THE BRAIN AMYLOID DEPOSITS OF ALZHEIMERS-DISEASE [J].
ABRAHAM, CR ;
SELKOE, DJ ;
POTTER, H .
CELL, 1988, 52 (04) :487-501
[2]   HIGH-MOLECULAR-MASS PROTEINS IN HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS [J].
ARGILES, A ;
MOURAD, G ;
AXELRUDCAVADORE, C ;
WATRIN, A ;
MION, C ;
CAVADORE, JC .
CLINICAL SCIENCE, 1989, 76 (05) :547-552
[3]   Structural and functional characterization of three human immunoglobulin kappa light chains with different pathological implications [J].
Bellotti, V ;
Stoppini, M ;
Mangione, PP ;
Fornasieri, A ;
Min, L ;
Merlini, G ;
Ferri, G .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1996, 1317 (03) :161-167
[4]   Review: Immunoglobulin light chain amyloidosis - The archetype of structural and pathogenic variability [J].
Bellotti, V ;
Mangione, P ;
Merlini, G .
JOURNAL OF STRUCTURAL BIOLOGY, 2000, 130 (2-3) :280-289
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   Aprotinin binding to amyloid fibrils [J].
Cardoso, I ;
Pereira, PJB ;
Damas, AM ;
Saraiva, MJM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (08) :2307-2311
[7]   APOLIPOPROTEIN-E CARBOXYL-TERMINAL FRAGMENTS ARE COMPLEXED TO AMYLOID-A AND AMYLOID-L - IMPLICATIONS FOR AMYLOIDOGENESIS AND ALZHEIMERS-DISEASE [J].
CASTANO, EM ;
PRELLI, F ;
PRAS, M ;
FRANGIONE, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (29) :17610-17615
[8]   Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation [J].
Castillo, GM ;
Cummings, JA ;
Yang, WH ;
Judge, ME ;
Sheardown, MJ ;
Rimvall, K ;
Hansen, JB ;
Snow, AD .
DIABETES, 1998, 47 (04) :612-620
[9]   The sulfate moieties of glycosaminoglycans are critical for the enhancement of β-amyloid protein fibril formation [J].
Castillo, GM ;
Lukito, W ;
Wight, TN ;
Snow, AD .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (04) :1681-1687
[10]   AMINO-ACID-SEQUENCE OF A GAMMA-VI PRIMARY (AL) AMYLOID PROTEIN (WLT) [J].
DWULET, FE ;
STRAKO, K ;
BENSON, MD .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1985, 22 (06) :653-660